A detailed history of Royal Bank Of Canada transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 49,161 shares of ANIK stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,161
Previous 48,112 2.18%
Holding current value
$1.21 Million
Previous $1.22 Million 1.88%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.57 - $28.47 $25,773 - $29,865
1,049 Added 2.18%
49,161 $1.25 Million
Q1 2024

May 15, 2024

SELL
$21.95 - $26.42 $89,687 - $107,952
-4,086 Reduced 7.83%
48,112 $1.22 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $44,438 - $56,059
2,406 Added 4.83%
52,198 $1.18 Million
Q3 2023

Nov 14, 2023

SELL
$16.98 - $26.1 $14,891 - $22,889
-877 Reduced 1.73%
49,792 $927,000
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $137,927 - $158,210
5,482 Added 12.13%
50,669 $1.32 Million
Q1 2023

May 15, 2023

BUY
$25.91 - $32.1 $417,721 - $517,516
16,122 Added 55.47%
45,187 $1.3 Million
Q4 2022

Feb 14, 2023

SELL
$23.85 - $31.91 $256,363 - $343,000
-10,749 Reduced 27.0%
29,065 $860,000
Q3 2022

Nov 14, 2022

SELL
$21.74 - $24.68 $17,348 - $19,694
-798 Reduced 1.96%
39,814 $947,000
Q2 2022

Aug 15, 2022

BUY
$20.4 - $25.53 $28,090 - $35,154
1,377 Added 3.51%
40,612 $907,000
Q1 2022

May 16, 2022

SELL
$24.7 - $36.54 $86,944 - $128,620
-3,520 Reduced 8.23%
39,235 $984,000
Q4 2021

Feb 14, 2022

BUY
$35.83 - $45.03 $10,892 - $13,689
304 Added 0.72%
42,755 $1.53 Million
Q3 2021

Nov 15, 2021

BUY
$38.75 - $44.47 $43,206 - $49,584
1,115 Added 2.7%
42,451 $1.81 Million
Q2 2021

Aug 16, 2021

BUY
$39.42 - $48.08 $1.63 Million - $1.99 Million
41,336 New
41,336 $1.79 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.